< Terug naar vorige pagina
Octrooi
Fused pyridine derivatives as kinase inhibitors
A series of substituted pyrido[3,2-d]pyrimidine and 1,5-naphthyridine derivatives of formula (I), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.
Octrooi-publicatienummer: WO2017055306
Jaar aanvraag: 2016
Jaar toekenning: 2018
Jaar van publicatie: 2017
Status: Aangevraagd
URI: link to Espacenet
Technologiedomeinen: Farmaceutische producten
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven